Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Biosimilar-Biologics'
Biosimilar-Biologics published presentations and documents on DocSlides.
Understanding Biologics Biologics and Biosimilars
by calandra-battersby
Animation: What Are Biologics?. Production of Bio...
Latin American Biologics/Biosimilars Conference
by giovanna-bartolotta
Presented by . the Alliance for Safe Bioloigic . ...
Biosimilars and biologics –
by gelbero
What does personalisation . mean . for you?. Ian N...
CHALLENGES FACED IN THE DEVELOPMENT OF BIOSIMILARS
by iamamercy
Dr.G.Hima. . Bindu. ...
Bio similars A Presentation
by kittie-lecroy
By. ANSHUL . SHARMA. Graduate Research Scholar. D...
Applying Biosimilars in Hematologic Cancers
by conchita-marotz
This program will include a discussion of off-lab...
Building a Biosimilars Pathway in the U.S.
by attentionallianz
Richard . Dolinar. , MD. Endocrinologist, Chairman...
Biosimilars are effective and safe and should immediately replace innovator molecules in the NHS
by myesha-ticknor
Dr Chris Deighton. Consultant Rheumatologist . Co...
Biologics Effectiveness and
by ruby
Safety (BEST) Initiative: . Pilot Year. Azadeh Sho...
From Small Molecules to Biologics: The Biotech Revolution
by trish-goza
New Opportunities for Universities and Small Biot...
Developing a biologics service:
by cheryl-pisano
a Virtual Biologics Clinic. Dr Ben Parker PhD, MR...
©Immunotrex Biologics 2014 CONFIDENTIAL
by conchita-marotz
1. PEG Nanoparticles: . Production . and Drug Del...
Category 1: Defining Terms
by jasmine
Clue: . A biologic product with no clinically mean...
What is the value of Real-World Evidence for Biosimilars?
by bitsy
Disclaimer. This panel is moderated by Dr. Delphin...
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
United Spinal Association
by alida-meadow
August, 2014. Biologics & Biosimilars: . An O...
Conference Series LLC Conferences
by mitsue-stanley
Conference Series LLC . is a pioneer and leading ...
Conference Series LLC
by trish-goza
Conferences. Conference Series LLC . is a pioneer...
Phil Johnson MS
by stefany-barnette
RPh. Safe School Meds, Principle Partner. Moffitt...
Biosimilars in the united states – Update on FDA Impleme
by test
James C. Shehan. Hyman, Phelps & McNamara, P....
Synergy Satellite Event - Biosimilars in colorectal cancer
by mia
– what's your gut feeling?. 25th Anniversary EAH...
The generic and biosimilar
by alida-meadow
perspective. Warwick Smith. Director General BGMA...
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by calandra-battersby
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
Comparison of US/EU Biosimilar
by aaron
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
U.S. Biosimilars: An Introduction
by calandra-battersby
Disclaimers. :. By 2016, 7 of the top 10 pharmace...
Comparison of US/EU Biosimilar
by myesha-ticknor
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
Biosimilar Biological Products
by luanne-stotts
2016 . Clinical Investigator . Training Course. S...
PhAMA Position on Biosimilar Medicines
by celsa-spraggs
Ms. Leah Goodman. Contents. Key Messages. An Over...
Comparison of US/EU Biosimilar
by danika-pritchard
Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...
MODULE 8. Follow-on drugs: generic, biosimilar
by alida-meadow
& non-biological similar medicinal products ....
Challenges in demonstrating biosimilarity and interchangeability of biosimilar products
by stefany-barnette
OMIC Group Biosimilars 2014. Hyderabad India. 27-...
ASBM Biosimilars
by phoebe-click
US Prescribers and Biosimilars Naming. Kevin Olso...
Education pack for patients with Rheumatoid Arthritis treated with Biologics and Targeted synthetic
by anderson
at Dudley Group NHS FT . Dudley Rheumatology RA VB...
Large scale evidence generation for the utilisation and safety of biologic medicines
by quinn
. Associate Professor Nicole Pratt . Quality use o...
MONTH DAY, 20XX PRESENTATION TITLE CAN
by walsh
BE UP TO TWO LINES. PRESENTATION SUBTITLE CAN BE A...
PRESS RELEASE
by norah
1 Biocon Biologics’ New Monoclonal Antibodies ...
New Facility Preparation
by yoshiko-marsland
for Pre-Approval . Inspection . ...
Inflammatory Bowel Disease
by kittie-lecroy
Anjali Morey, M.D., Ph.D.. Digestive Specialists,...
How to Manage ISRs That Occur With Injectable Agents in Psoriasis
by faustina-dinatale
Introduction. MOA and Dosing of Approved Biologic...
Immunology
by tatyana-admore
of Asthma . through Biologics . Private Practice ...
Load More...
